IDEAYA Biosciences's market cap is currently $1.90B. The company's EPS TTM is $-3.297; its P/E ratio is ―; IDEAYA Biosciences is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 7.00M	$ 23.39M	$ 50.93M	$ 27.94M	$ 19.54M
Gross Profit	$ 7.00M	$ 19.38M	$ 48.83M	$ 26.22M	$ -20.16M
Operating Income	$ -326.98M	$ -134.43M	$ -62.50M	$ -50.27M	$ -35.34M
EBITDA	$ -326.98M	$ -130.42M	$ -60.40M	$ -48.54M	$ -33.96M
Net Income	$ -274.48M	$ -112.96M	$ -54.81M	$ -47.53M	$ -32.27M
Balance Sheet
Cash & Short-Term Investments	$ 676.32M	$ 525.11M	$ 373.15M	$ 368.06M	$ 283.58M
Total Assets	$ 1.12B	$ 649.32M	$ 387.97M	$ 381.35M	$ 298.27M
Total Debt	$ 19.17M	$ 2.87M	$ 3.48M	$ 5.18M	$ 6.72M
Net Debt	$ -65.21M	$ -154.15M	$ -65.15M	$ -86.86M	$ -65.31M
Total Liabilities	$ 64.94M	$ 28.23M	$ 387.97M	$ 381.35M	$ 298.27M
Stockholders' Equity	$ 1.06B	$ 621.09M	$ 349.45M	$ 301.51M	$ 198.27M
Cash Flow
Free Cash Flow	$ -251.44M	$ -117.59M	$ -90.62M	$ -58.42M	$ 54.97M
Operating Cash Flow	$ -247.58M	$ -115.22M	$ -87.17M	$ -55.78M	$ 55.46M
Investing Cash Flow	$ -502.56M	$ -158.46M	$ -33.40M	$ -69.67M	$ -146.24M
Financing Cash Flow	$ 677.55M	$ 362.72M	$ 97.17M	$ 145.45M	$ 128.75M

Currency in USD

IDEAYA Biosciences Earnings and Revenue History

Income Statement >

IDEAYA Biosciences Debt to Assets

Balance Sheet >

IDEAYA Biosciences Cash Flow

Cash Flow >

IDEAYA Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing